Year: 2022

BGNE-LOGO-HORTZ-COLOR-BREDMID-RGB-9

BeiGene Receives European Commission Approval for BRUKINSA® (zanubrutinib) for the Treatment of Adults with Chronic Lymphocytic Leukemia (CLL)

BRUKINSA is the only Bruton’s Tyrosine Kinase (BTK) inhibitor to achieve superiority over IMBRUVICA® (ibrutinib) in relapsed/refractory CLL. BRUKINSA also...

logo-89

Singapore Bunker Fuel (High Sulfur Fuel Oil, Low Sulfur Fuel Oil, Marine Gas Oil) Markets, Competition, Forecast & Opportunities, 2017-2021 & 2022-2027 – ResearchAndMarkets.com